reference/19369585

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19369585

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Multicenter Study
endingPage	7078
issn	1557-3265 1078-0432
issueIdentifier	23
pageRange	7071-7078
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	7071
bibliographicCitation	Dittrich C, Petruzelka L, Vodvarka P, Gneist M, Janku F, Kysela T, Melemed A, Latz J, Simms L, Krejcy K. A phase I study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer. Clin Cancer Res. 2006 Dec 01;12(23):7071–8. doi: 10.1158/1078-0432.ccr-05-2829. PMID: 17145830.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcb7b1d79fb664bc4183ac3ac38eef05 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d009044cfc9fc61beb571bb3ce62fcf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74dd295d62d35ea7121415ed10a52856 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b46dc98653480daf493467be8134b01 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f502cdb8d93c6ab7a139c29a1c3078d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc117a2e783a5275879af330e5776c80 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_90b615dd32f975aa23f2e163b770aedb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91c91da5ecdf09e1f17789596bddb3d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96d2531955d33b2d0d623846c196ac1a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66bd9d2de193a1731f80f5e8895f01c5
date	2006-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/17145830 https://doi.org/10.1158/1078-0432.ccr-05-2829
isPartOf	https://portal.issn.org/resource/ISSN/1078-0432 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1557-3265
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A Phase I Study of Pemetrexed (ALIMTA) and Cyclophosphamide in Patients with Locally Advanced or Metastatic Breast Cancer
discusses	http://id.nlm.nih.gov/mesh/M0009376 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0227083 http://id.nlm.nih.gov/mesh/M0009679
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009364Q000188 http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D005971Q000008 http://id.nlm.nih.gov/mesh/D006147Q000031 http://id.nlm.nih.gov/mesh/D009364Q000556 http://id.nlm.nih.gov/mesh/D001943Q000556
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D000971Q000493 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D005971Q000493 http://id.nlm.nih.gov/mesh/D003520Q000493 http://id.nlm.nih.gov/mesh/D006147Q000009 http://id.nlm.nih.gov/mesh/D005971Q000009 http://id.nlm.nih.gov/mesh/D011237 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D003520Q000009 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D020714 http://id.nlm.nih.gov/mesh/D006147Q000493 http://id.nlm.nih.gov/mesh/D000068437 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D006147Q000008 http://id.nlm.nih.gov/mesh/D007275 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168322524 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7732 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135413520 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.6.1.1 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135564751 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID936 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136068113 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135916113 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136253316 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101068009

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128866026 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837

Total number of triples: 90.